Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113636968B introduces a ruthenium-catalyzed route for synthesizing pharmaceutical intermediates with exceptional atom economy and simplified manufacturing processes.
Novel chiral indolinopyrrole synthesis via phosphoric acid catalysis achieves high enantioselectivity and scalability, enabling cost-effective API intermediate production for oncology therapeutics.
Patent-CN-7 introduces an efficient one-step palladium-catalyzed method for indolo[2,1a]isoquinoline synthesis offering significant cost reduction and scalable production capabilities.
Patent CN115286556B enables high-purity indolinone ester production using green solvents and catalysts, reducing lead time while enhancing supply chain reliability for pharma intermediates.
Patent CN113549070B enables efficient maravirol production through mild condition chemistry with high purity output, enhancing supply chain reliability for HIV treatment APIs.
Patent CN106188044A details an iodine-catalyzed method for synthesizing thiolated imidazo[1,5-a]N-heterocycles without transition metals, enabling mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Patent CN115286553B introduces a novel nickel-catalyzed carbonylation method for indole compounds offering simplified synthesis and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN118702710B introduces catalyst-free visible light synthesis enabling sustainable scale-up of high-purity organoboron compounds with significant cost reduction potential.
Patent CN110183443B enables efficient indolo[3,2-c]quinoline production through rhodium-catalyzed cyclization with broad substrate scope ensuring supply chain reliability and cost reduction.
Patent CN102898327B enables eco-friendly DMAD production using dimethyl carbonate, ensuring supply chain reliability and significant cost savings for pharmaceutical intermediates.
This patent details a novel silver oxide-promoted cycloaddition process enabling high-yield production of trifluoromethyl imidazoles with simplified purification and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN118619879A introduces rhodium-catalyzed synthesis enabling high-purity trifluoromethyl enaminones with simplified scale-up and enhanced supply chain reliability.
Patent CN118994186B enables high-yield copper-catalyzed synthesis of chiral dihydrofuranocoumarins with up to 99% ee enhancing supply chain reliability and reducing manufacturing costs for pharma intermediates
Patent CN113307790B enables efficient triazole synthesis without heavy metals, enhancing supply chain reliability and reducing manufacturing costs for pharmaceutical intermediates.
Novel Pd-catalyzed method enables atom-economical lactam synthesis using air as oxidant with enhanced purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN115246786B enables efficient synthesis of indole and benzoxazine intermediates through palladium catalysis with simplified operations and scalable production for high-purity pharmaceutical applications.
Patent CN117164544A enables cost-effective pyrone derivative synthesis using palladium catalysis with enhanced scalability and purity for pharmaceutical manufacturing supply chains.
This patent introduces a novel Vilsmeier-based method for synthesizing polysubstituted pyridinones with high yields and mild conditions enabling cost-effective production and reliable supply chain for pharmaceutical intermediates
Novel metal-free method enables scalable production of high-purity triazole intermediates with simplified manufacturing processes for pharmaceutical supply chains.
This patent reveals a novel palladium-catalyzed method for pyrrolinone intermediate synthesis enabling high-purity pharmaceutical compounds with simplified scale-up and enhanced supply chain reliability for global manufacturers.